Peter Dollahite

Senior commercial operations leader with 14+ years of experience building and scaling sales operations, analytics, and financial rigor across healthcare and telecommunications. Proven ability to partner with CROs, Presidents, and CFOs to drive revenue growth, forecast accuracy, sales productivity, and incentive effectiveness. Deep expertise in forecasting, incentive compensation, CRM transformation, and data-driven decision support at enterprise scale.

Director, Sales Operations — US Advanced Wound Management - SMITH & NEPHEW - Fort Worth, TX

(2022-01)

Lead national Sales Operations function for 14 sales teams and 900 field sellers, supporting an $950M annual revenue business (growing at 10% CAGR – above industry standard). Member of the US Advanced Wound Management executive leadership team (12-member team charged with setting the strategic vision and delivery/execution of the US Advanced Wound Management franchise).

• Own end-to-end forecasting, quota setting, territory design, and pipeline analytics, improving visibility and decision-making for senior commercial leadership
• Design and manage incentive compensation plans aligned to growth priorities, ensuring performance clarity, governance, and seller engagement
• Partner with Sales Leadership, Finance, and Commercial Strategy to identify productivity opportunities, optimize coverage models, and support strategic growth initiatives
• Led enterprise CRM deployment and adoption, transforming field reporting and standardizing performance metrics across the sales organization
• Build, mentor, and lead a high-performing Sales Ops and Analytics team delivering executive-level insights and actionable recommendations to leadership

Finance Business Partner — US Advanced Wound Management - SMITH & NEPHEW - Fort Worth, TX

(2018-01 - 2021-12)

Senior FP&A leader responsible for commercial P&L oversight, forecasting, budgeting, long-range planning, and strategic financial modeling. Served as the primary finance partner to the President of Global Advanced Wound Management with direct reporting to the Global CFO.

• Owned financial performance and analytics for Santyl, the company's largest pharmaceutical brand
• Delivered deep commercial insights across distributor demand (852/867), pricing, rebates, gross-to-net, volume, ASP, TRx, and prescriber trends
• Influenced pricing strategies, investment decisions, and sales initiatives through data-driven insights and executive-ready reporting

Lead Financial Analyst (Rotational Leadership Roles) - AT&T INC. - Dallas, TX

(2012-01 - 2018-12)

Held progressive FP&A and Sales Operations roles supporting multi-billion-dollar business units across Mobility, Business, Entertainment, and Technology. Recognized as a Finance HiPo, "Far Exceeds" performer, and multiple award recipient.

• Led forecasting, KPI development, executive reporting, and operational analytics presented to C-Suite leadership
• Selected for high-impact teams reporting directly to the CFO during critical transformation initiatives

MBA - Finance - Texas Christian University – M.J. Neeley School of Business

BS - Human & Organizational Development - Vanderbilt University